After six months the subjects knew the genetic test result. During this third visit the physician and the psychologist together communicated the outcome of the test, the possible involvement of the family into genetic counseling and the risk-reducing strategies, they help Trichostatin A purchase the subjects to express emotions, doubts, and requests focused on the genetic test outcome and on how to
communicate the outcome to the sibling or children [24, 25]. The local Ethic Committee approved the counseling procedures. At the end of each counseling session the psychologist asked to the patients an informed Ku-0059436 clinical trial consent to complete questionnaires and psychological tests. During the second counseling step, only eligible subjects were proposed to give the blood sample; while for the others or non eligible subjects were organized an “”ad hoc”" surveillance programmes. This study refers to the data obtained by the questionnaires completed after the first genetic counseling session by 130 subjects. The sample was made up of eligible and non eligible subjects. Instruments The questionnaires
and psychological tests evaluate the following variables. Demographic and medical characteristics Data regarding age, geographic origin, civil status, number of children, education, religion and whether they were religious-practicing or non-practicing, eligibility, pathology, number Phospholipase D1 of relatives affected by cancer of the breast and/or ovaries and the total number of
relatives affected by any type of tumour were collected. Cancer Risk Perception (CRP) An item adapted from MAPK Inhibitor Library supplier previous research was used to evaluate the perception of the risk of developing a tumour: “”Indicate with a cross, on a scale from 0 to 100, that which you think is your current percentage risk of developing a tumour, or redeveloping a tumour of the breast and/or ovaries”" [26, 17]. The answer was given on a visual analogue scale from 0 to 100 (100 corresponds to the highest risk). The scale is a ten centimetres line and each millimetre corresponds to one point percent. Genetic Risk Perception (GRP) An item adapted from previous research was used to evaluate the perception of the risk of being a carrier of the genetic mutation BRCA1/BRCA2 [10].